People
Manuel Hidalgo Medina
Manuel Hidalgo Medina is advisory board at Eckuity Capital. Oncology researcher and public-company director. Bristol Myers Squibb’s 2026 proxy dates his Weill Cornell professorship and division-chief tenure to 2019–2025; Eckuity’s older Cornell headline is qualified accordingly.
Roles
EckuityCapital
CurrentAdvisory Board